Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
Abstract Background Glioblastoma is a rapidly proliferating tumor. Patients bear an inferior prognosis with a median survival time of 14-16 months. Proliferation and repopulation are a major resistance promoting factor for conventionally fractionated radiotherapy. Tumor-Treating-Fields (TTFields) ar...
Main Authors: | N. Guberina, C. Pöttgen, S. Kebir, L. Lazaridis, C. Scharmberg, W. Lübcke, M. Niessen, M. Guberina, B. Scheffler, V. Jendrossek, R. Jabbarli, D. Pierscianek, U. Sure, T. Schmidt, C. Oster, P. Hau, A. L. Grosu, M. Stuschke, M. Glas, Y. Nour, L. Lüdemann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01521-7 |
Similar Items
-
A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights
by: Li Xing, et al.
Published: (2023-09-01) -
Dosimetric Evaluation of The Tomotherapy, Non-coplanar and Coplanar IMRT Plannings for Total Scalp Irradiation
by: Songul Barlaz Us, et al.
Published: (2015-06-01) -
Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
by: Ellaine Salvador, et al.
Published: (2022-09-01) -
Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
by: Shupeng Li, et al.
Published: (2022-09-01) -
Progress on TTFields combined with other therapies for glioblastoma treatment: A narrative review
by: Yong Cao, et al.
Published: (2022-01-01)